Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya29909Editorial articleПередовая статьяMetabolic syndrome of insulin resistance: basic conception and consequences (a review)Метаболический синдроминсулинорезистентности: основная концепция и следствие (обзор)StarkovaN ТСтарковаН Т

Московский государственный медико-стоматологический университет

DvoryashinaI VДворяшинаИ В

Северный государственный медицинский университет

Московский государственный медико-стоматологический университетСеверный государственный медицинский университет150320047910NO10 (2004)ТОМ 79, №10 (2004)545709042020Copyright ©; 2004, Consilium MedicumCopyright ©; 2004, ООО "Консилиум Медикум"2004Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/29909

reviewmetabolic syndrome of insulin resistanceinsulin resistancehyperinsulinemiadyslipidemiaobesityatherosclerosisdiabetes mellitus of type 2arterial hypertensionобзорметаболический синдром инсулинорезистентностиинсулинорезистентностъгиперинсулинемиядислипидемияожирениеатеросклерозсахарный диабет типа 2артериальная гипертонияReaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1596-1607.Laakso M. Insulin resistance and coronary heart disease. Curr. Opin. Lipidol. 1996; 7: 217-226.Stout R. W. Diabetes and atherosclerosis: the role of insulin. Diabetologia 1979; 16: 141-150.Pyorala K., Savolainen E., Kaukola S. Haapakoski J. et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9,5-year followup of the Helsinki Policemen Study Population. Acta Med. Scand. 1985; suppl. 701: 38-53.Despres J. P., Lamarche В., Mauhege P. et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease.N. Engl. J. Med. 1996; 334: 952-957.Fontbonne A., Charles M. A., Thibult N. et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population; the Paris Prospective Study, 15-year followup. Diabetologia 1991; 34: 356-361.Fontbonne A., Eschwege E., Cambien F. et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304.Welbom T. A., Knuiman M. W., Ward N., Whittall D. E. Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabet. Res. Clin. Pract. 1994; 26: 51-59.Kuusisto J., Mykkanen L., Pyorala K., Laakso M. Hyperinsulinemic hyperinsulinemia: a new risk indicator for coronary heart disease. Circulation 1995; 91: 831-837.Logan R. L., Riemersma R. A., Thomson M. et al. Risk factors for ischemic heart disease in normal men aged 40: Edinburgh- Stockholm Study. Lancet 1978; 323: 949-950.Yarnell J. W. G., Sweetnam P. M., Marks V. et al. Insulin in ischemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly Prospective Study. Br.Heart J. 1994; 71: 293-296.Welin L., Eriksson H., Larsson B. et al. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992; 35: 766-770.Orchard Т. J., Eichner J., Kuller L. H. et al. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann. Epidemiol. 1994; 4: 40-45.Ferrara A., Barret-Connor E., Edilstein S. L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study. Am. J. Epidemiol. 1994; 140: 857-869.Ruige J. В., Assendelft W. J. J., Dekker J. M. et al. Insulin and risk of cardiovascular disease (a meta-analysis). Circulation 1998; 97: 996-1001.Howard G., O'Leary D. H., Zaccaro D. et al. Insulin sensitivity and atherosclerosis. Circulation 1996; 93: 1809-1817.Despres J. P., Lemieux S., Lamarche B. et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesi ty and therapeutic implications. Int. J. Obes. 1995; 19 (suppl. 1): S76-S86.Bjomtorp P. The regulation of adipose tissue distribution in humans. Int. J. Obes. 1996; 20 (4): 291-302.Bjomtorp P. Visceral obesity: "Civilization Syndrome". Obes. Res. 1993; 1 (3): 206-222.Дворяшина И. В. Ожирение и метаболический инсулинорезистентный синдром при ишемической болезни сердца: Дис.д-ра мед. наук. М.; 2001.Старкова Н. Т., Летова Е. К. Генерализованная липодистрофия в клинической практике. М.: Медицина; 2001.Davidson M. В. Clinical implications of insulin resistance syndromes. Am. J. Med. 1995; 99: 420-426.Despres J. P., Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr. Opin. Lipidol. 1994; 5: 274-289.Stern M. P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44: 369-374.Cannon R. O., Camici P. G., Epstein S. E. Pathophysiological dilemma of syndrome X. Circulation 1992; 85 (3): 883-892.Иоселиани Д. Г., Ключников И. В., Смирнов М. Ю. Синдром X (вопросы определения, клиники, диагностики, прогноза и лечения). Кардиология 1993; 2: 80-84.Саютина Е. В. Изучение влияния эндотелий-зависимой вазодилатации на перфузию миокарда у пациентов с болевым синдромом в грудной клетке, факторами риска развития атеросклероза и интактными или малоизмененными коронарными артериями: Автореф. дис.канд. мед. наук, М.; 1998.Executive summary of the third report of the National Chole terol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.